Understanding the genetic features of high-risk gastric precancerous lesions

Project 1 - Molecular and Cellular Determinants of High Risk Gastric Precancerous Lesions

NIH-funded research Stanford University · NIH-10932168

This study is looking at the early signs of high-risk stomach cancer to help us understand how they develop, especially in people with Helicobacter pylori infections, so we can find better ways to spot and prevent stomach cancer in the future.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionStanford University NIH-funded
Lab location1 site (Stanford, United States)
Project IDNIH-10932168 on NIH RePORTER

What this research studies

This research investigates the molecular characteristics of high-risk gastric cancer precursor lesions to better understand their progression. The team, led by Dr. Hanlee Ji, will analyze gene expression profiles and cellular properties of these lesions using advanced techniques like RNA sequencing and spatial transcriptomics. By examining the genetic makeup of these lesions, the research aims to identify specific markers that indicate a higher risk of developing gastric cancer, particularly in patients with Helicobacter pylori infections. This work could lead to improved detection and prevention strategies for gastric cancer.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with high-risk gastric intestinal metaplasia or those with a history of Helicobacter pylori infection.

Not a fit: Patients with low-risk gastric lesions or those without any precancerous conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection and targeted prevention strategies for patients at high risk of gastric cancer.

How similar studies have performed: Previous research has shown promise in identifying genetic markers associated with cancer progression, suggesting that this approach could yield valuable insights.

Where this research is happening

Stanford, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer Cause
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.